Caitong International Asset Management’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
WCA
PVM
VCM
NI
Caitong International Asset Management's HCAT Position: Q1 2026 in Review
Caitong International Asset Management increased its Health Catalyst (HCAT) stake by 638% in Q1 2026, buying an estimated $110K and bringing the position to 67,629 shares worth $85.9K. The position accounts for 0.02% of the portfolio, ranked #625.
Caitong International Asset Management first reported a position in HCAT in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.
- Caitong International Asset Management held 67,629 shares of Health Catalyst worth $85.9K as of Q1 2026.
- Caitong International Asset Management bought 58,468 Health Catalyst shares in Q1 2026, an estimated $110K.
- Health Catalyst made up 0.02% of Caitong International Asset Management's portfolio in Q1 2026, its #625 holding.
- Caitong International Asset Management first reported a position in Health Catalyst in Q4 2025 and has held it in 2 quarters since.
- 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.
Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.